Replies to post #19879 on CytoSorbents Corporation (CTSO)

[Canes16]

It is evident to me that the significant increase in daily volume is a direct result of the Company being categorized as a corona stock. With that said, once the tide rolls out, I do feel like we will be impacted. The analysts are also going to start asking what % of sales is related to the virus. Every company will go through this, so Dr. Chan better start thinking about how to respond to the question.

On the other hand, we have initiatives in place that will help to offset any virus impact in the future. This Company needs to produce results as always. It will be critical to the mid-term stock price. I'm hoping the REMOVE trial is not delayed because of the virus. This is a real concern of mine.

Dr. Chan just needs to get this company to produce...period.

I will be extremely disappointed if we walk away from this virus with no FDA approval.

[B52T38]

Question, Techxen: you just mentioned the possible "commercial collaboration in China with China Medical Systems." However, assuming the filter you uncovered earlier (HA380 made by Chinese firm Jafron) can do everything ours can do, would the Chinese gov't even allow our filter to be sold in China? I know we sell other stuff to the Chinese that they make as well, but I wonder if the Chinese gov't might try and suprress our sales to maximize their home-grown filter. They might call the HA380 a "strategic" medical device or something.

In short, given the existence of HA380, and assuming it works as well as ours (maybe a big IF), how much do you think this will impact CTSO's potential China market?